NEW YORK, June 23, 2023 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulcrum Therapeutics, Inc. (NASDAQ: FULC). To receive updates on the lawsuit, fill out the form:…
NEW YORK, June 23, 2023 /PRNewswire/ — Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulcrum Therapeutics, Inc. (NASDAQ: FULC). To receive updates on the lawsuit, fill out the form:…